Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs
about
Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primatesNasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in miceVesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primatesCurrent ebola vaccinesMucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responsesA Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary ReportEbolavirus vaccines for humans and apesClinical development of Ebola vaccinesMouse models for filovirus infectionsAntigenic subversion: a novel mechanism of host immune evasion by Ebola virusNeutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against itStructure of the Ebola virus glycoprotein bound to an antibody from a human survivorAd35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus speciesEbola and Marburg virus vaccines.A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola Virus"Filoviruses": a real pandemic threat?Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirusEnhanced protection against Ebola virus mediated by an improved adenovirus-based vaccineDemonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus SpeciesTowards broad protection against Ebolaviruses.Vaccinating captive chimpanzees to save wild chimpanzees.Ebola Vaccine: How Far are we?A replicating cytomegalovirus-based vaccine encoding a single Ebola virus nucleoprotein CTL epitope confers protection against Ebola virusProtective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever.Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge.Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain.Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, doubEbolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trialRecombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primatesVesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses.Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy.The emergence of ebola as a global health security threat: from 'lessons learned' to coordinated multilateral containment efforts.Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice.Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trialRecombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challengeEvasion of the interferon-mediated antiviral response by filoviruses.Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus.
P2860
Q21090120-62272C21-88D4-45B6-A0BD-9E1478EB86A4Q21092172-50B0FCAF-58D8-4BE7-9E69-E1662DF0AD47Q21131585-4D56FD82-F920-43C2-A47E-F66351B8CBE4Q21534720-FD332379-0022-49E5-8051-F1449BA4018CQ21562420-8C5C34F1-4F6B-4189-ACE6-F6E7298DDBDDQ24289295-DC83F01A-ED29-413A-AE84-DB4BAC128931Q24631696-ED6BD737-9AF8-4A70-B782-1FEC79CCF772Q26775792-E157FF05-B4C7-442D-BFCB-6F4B17F4344BQ27011569-F96CDFB7-7F5E-4B6D-9C7C-995F4574FB3CQ27339643-BFDEC7FD-87C9-4013-8150-02509FD07D08Q27489891-6A0B1AC1-639B-400B-A948-BD527A8D36C5Q27651112-1913E76B-9CF0-48FA-A08E-FA6C08D8699CQ28485505-9887225D-3379-4AD3-ADB1-1901807AB3F3Q30234637-9ABA5520-1BC6-4AE3-85AC-724739D0D764Q30235073-BD02AF76-FD81-47A6-B059-D3DBECA6AA35Q30384090-BDC66077-1029-4990-8DF6-EB68BBC7B39BQ30724121-43D5D81A-7202-4228-A1C6-AB389AB2FBF9Q33434415-0A329537-A613-4CED-B37F-0E5EB550EF63Q33587515-B141D2CA-C9AB-4CF4-B433-F48037D7CDC4Q33745567-23C9227D-369D-4BE8-8C80-E37FC9CD877AQ33790197-18DD3E02-3CA4-4933-823F-FB2A77237DE2Q33831877-57894BB3-B469-4248-BD81-2FCB85CA1B23Q34000122-944E6D40-8868-48B7-BC42-BB2C53743137Q34257290-4DC6646E-682B-4B73-8318-54805F8A68BDQ34437167-C61200AD-18A5-4DD1-B6C0-A7246C054725Q34463780-AA3875B8-2ED2-44D9-BE21-88EFBEDD4D55Q34488551-4595150A-B9A4-4463-B633-5B0A5AC7BDEBQ34500955-64DE459A-0C39-436D-8756-52DB75D0D5B5Q34540207-412CC658-777E-4385-B1D4-449301D19C96Q34571072-C099B503-A0F9-435A-A421-231FF862C8FEQ34589949-13928F83-D94A-4CAD-A3C4-007351994123Q34598925-67551129-A371-477B-90EE-CBA3E5637BF8Q34606818-0AF4051C-D0F8-46CD-B808-85A0581F72F9Q34632946-F8B1ED7C-F210-448C-83A5-4C15E7FE38B5Q34699060-992C9A11-311A-4F5D-8FD5-C156A4533293Q34761889-5AD56E9A-0351-4275-B121-6F74219BC4ECQ35055198-2B0EC8CA-F04F-4983-94BB-D1A471970DE4Q35076828-3C9BDD30-A1B0-46EC-A1B7-79116A523A46Q35260239-45342284-67FC-49F2-BF30-D5594CF648A0Q35300062-805688F1-F353-46EA-812E-693F7CED067B
P2860
Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Immune protection of nonhuman ...... vectors encoding modified GPs
@ast
Immune protection of nonhuman ...... vectors encoding modified GPs
@en
type
label
Immune protection of nonhuman ...... vectors encoding modified GPs
@ast
Immune protection of nonhuman ...... vectors encoding modified GPs
@en
prefLabel
Immune protection of nonhuman ...... vectors encoding modified GPs
@ast
Immune protection of nonhuman ...... vectors encoding modified GPs
@en
P2093
P2860
P50
P921
P3181
P1433
P1476
Immune protection of nonhuman ...... vectors encoding modified GPs
@en
P2093
Devon J Shedlock
Jerome H H V Custers
Joan B Geisbert
Laurie Lamoreaux
Maria G Pau
Mario Roederer
Nancy J Sullivan
Paul M Popernack
Richard A Koup
P2860
P3181
P356
10.1371/JOURNAL.PMED.0030177
P407
P577
2006-06-01T00:00:00Z